Mechanistic studies revealed that tumor-derived ANG binds epidermal growth factor receptor (EGFR) on tumor-associated macrophages (TAMs), activating RhoA-dependent cytoskeletal remodeling and autocrine ALK5/TGFβ signaling. Here, TGFB1 is linked to neoplasm.